Neck Pain in Office Workers During Covid 19 Pandemic

May 13, 2022 updated by: Betül Çiftçi Tepeli, Kırklareli University

Neck Pain in Office Workers and Remote Workers During Covid 19 Pandemic

Work content of office workers are using computers, conferences, presentations and talking on the phones. Static postures and repetitive writing and reading activities at inappropriate body postures are the most common activities of office workers. Decreased physical activity and prolonged computer use cause occupational safety problems and musculoskeletal problems. Neck pain is one of the most common problem in office workers and the studies have shown the incidence of neck pain in office workers is 34-49% .

The aim of this study to evaluate the effects of remote employee in neck pain in Office workers during covid 19 pandemic

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The data of study was obtained by using online questionnaire. The questionnaire was generated through Google forms and the online questionnaire link was delivered via e-mail to office workers. The questionnaire link was active within 3 months for data collection. The information about study was stated and before answering the questionnaire, all participants were asked whether they were willing to participate in the study and thus all participants have declared voluntary for the study. All participants were employees such as clerical or administrative work in an office. The inclusion criteria were as follows; (a) being an office worker or remote employee; (b) aged between 18 and 55 years; (c). had a diagnosis with myofascial pain in neck. The exclusion criteria were as follows: (a) having a history of surgery in neck region; (b): a diagnosis with skeletal muscle diseases, chronic kidney diseases, chronic liver failure, malignancy and neurologic diseases; (c): having cognitive impairment that affects answering the online questionnaire properly; (d): having internet access and not being able to complete the online questionnaire; (e): being pregnant. The Beck Depression Inventory (BDI), The Nottingham Health Profile (NHP), Neck Pain and Disability Scale (NPDS), Pittsburgh Sleep Quality Index (PSQI), The Nottingham Health Profile (NHP) and demographic form were obtained

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
139

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Kırklareli, Turkey
        • Kırklareli University
      • Kırklareli, Turkey, 39750
        • Kırklareli University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

office workers

Description

Inclusion Criteria:

being an office worker or remote employee aged between 18 and 55 years had a diagnosis with myofascial pain in neck.

Exclusion Criteria:

  • having a history of surgery in neck region a diagnosis with skeletal muscle diseases, chronic kidney diseases, chronic liver failure, malignancy and neurologic diseases having cognitive impairment that affects answering the online questionnaire properly having internet access and not being able to complete the online questionnaire being pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The Beck Depression Inventory (BDI)
Time Frame: questionnaire takes five minutes
The BDI has 21 items that describe symptoms of depression. The questionnaire is in a multiple-choice format, and each item has a four-point scale variable from 0 (absent) to 3 (severe). The minimum score is 0 and the maximum score is 63
questionnaire takes five minutes
The Nottingham Health Profile (NHP)
Time Frame: questionnaire takes five minutes
The NHP has two parts. The first part of the NHP has six domains that include pain, emotional reaction, sleep, social isolation, physical abilities, and energy level. The second part of the NHP assesses the presence of difficulties with performing daily activities
questionnaire takes five minutes
Neck Pain and Disability Scale (NPDS)
Time Frame: questionnaire takes five minutes
The NPDS contains 20 items related with 4 dimensions as neck problems, pain intensitiy, emotion-cognition and interference with life activities. Each item is a 100 mm VAS with 6 sections from 0 to 5 marked at equal intervals. The score of items is ranging 0 (no pain or activity limitation) and 5 ( much pain or maximal limitation ). activities. the range of total score is 0 to100 and higher score indicate greater disability.
questionnaire takes five minutes
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: questionnaire takes five minutes
The PSQI consists of 24 questions to assess patients'sleep dysfunction. 19 questions about sleep duration, latency and the frequency and severity of specific sleep-related problems. 5 questions are answered by the patient's bed partner or roommate and these five questions are used for clinical purposes. PSQI has seven components and the components are added to get global PSQI score. The global score has a range 0-21 and higher scores show lower sleep quality
questionnaire takes five minutes
demographic form
Time Frame: questionnaire takes five minutes
Sociodemographic features including age, gender, marital status, education level, comorbid diseases, height, weight, kind of working (office worker or remote employee) were assessed.
questionnaire takes five minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Kırklareli University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: betül çiftçi, Kırklareli University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
October 6, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 8, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 12, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 17, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 13, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • E-69456409-199-4707

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neck Pain

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings